Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Research analysts at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued on Tuesday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

CO stock opened at $1.01 on Tuesday. The company has a 50 day simple moving average of $1.09 and a 200 day simple moving average of $1.35. The stock has a market cap of $122.77 million, a price-to-earnings ratio of 1.58 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.